Exploratory study of a single dose of methotrexate for the treatment of stable tubal ectopic pregnancy

Registry ID

EUCTR2020-004592-40

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE4

Sponsor

University of Edinburgh

Start date

2020-10-26

Last update

2026-08-16

Conditions

• Ectopic Pregnancy

Summary

To explore the safety of 100 mg/ml dose of MTX in patients who routinely would receive 85 mg or lower based on their body surface area.

Locations

• , , UK

Related clinical trials

• Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
• Doppler Flow in Tubal Ectopic Pregnancy in Diagnosis as a Predictor of Treatment Success - Conservative and MTX Treatment
• Posttraumatic Stress Disorder in Ectopic Pregnancy
• Methotrexate Treatment in Cases of Ectopic Pregnancy With Relative Contraindications
• Comparison of vNOTES and Laparoscopic Salpingectomy in the Surgical Treatment of Ectopic Pregnancy
• Use of Letrozole for Ectopic Pregnancy

View on source registry